Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature

[1]  B. Egan,et al.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. , 2010, JAMA.

[2]  S. Oparil,et al.  Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension , 2009, Journal of hypertension.

[3]  W. Elliott.  Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events , 2009 .

[4]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[5]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[6]  J. Staessen.  Blood pressure lowering for the primary and secondary prevention of stroke (OR07-02) , 2008 .

[7]  C. Mathers,et al.  Preventing stroke: saving lives around the world , 2007, The Lancet Neurology.

[8]  J. Staessen,et al.  Oral renin inhibitors , 2006, The Lancet.

[9]  Li-sheng Liu,et al.  The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients , 2005, Journal of hypertension.

[10]  Fan Wu,et al.  Preventing chronic diseases in China , 2005, The Lancet.

[11]  J. Staessen,et al.  Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention , 2005, Hypertension.

[12]  A. Hofman,et al.  The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients , 2005, Blood pressure.

[13]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[14]  F. Messerli,et al.  Do thiazide diuretics confer specific protection against strokes? , 2003, Archives of internal medicine.

[15]  F. Turnbull.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[16]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[17]  A. Hofman,et al.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial , 2003, Journal of hypertension.

[18]  Jing Chen,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension in China , 2002, Hypertension.

[19]  J. Bosch,et al.  Use of ramipril in preventing stroke: double blind randomised trial , 2002, BMJ : British Medical Journal.

[20]  O. Godefroy,et al.  Age-adjusted stroke incidence increase: could angiotensin AT1 receptor antagonists enhance stroke prevention? , 2002, Stroke.

[21]  Johan P Mackenbach,et al.  Income inequality and population health , 2002, BMJ : British Medical Journal.

[22]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[23]  D. Johnston.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.

[24]  J. Achard,et al.  Journal of Renin-angiotensin-aldosterone System Journal of Renin-angiotensin-aldosterone System Non-at1-receptor-mediated Protective Effect of Angiotensin against Acute Ischaemic Stroke in the Gerbil Journal of Renin-angiotensin-aldosterone System Additional Services and Information for Journal of t , 2022 .

[25]  B. Neal.  The Blood Pressure Lowering Treatment Trialists' Collaboration , 2001 .

[26]  S. MacMahon,et al.  PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee. , 2000, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[27]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[28]  S. Yusuf,et al.  Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53. , 2000 .

[29]  Jin-Moo Lee,et al.  The changing landscape of ischaemic brain injury mechanisms , 1999, Nature.

[30]  H. Schunkert,et al.  β Adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics , 1998, Heart.

[31]  D. Murphy,et al.  Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies , 1995, The Lancet.

[32]  Pats-Collaborating-Group-.  Post-stroke antihypertensive treatment study. A preliminary result , 1995 .

[33]  B. Olofsson,et al.  Atenolol in Secondary Prevention after Stroke , 1995 .

[34]  L. Wilkins.  Trial of Secondary Prevention With Atenolol After Transient Ischemic Attack or Nondisabling Ischemic Stroke , 1993, Stroke.

[35]  F. Brackman,et al.  Cardiovascular protective properties of indapamide. , 1990, The American journal of cardiology.

[36]  J. Savineau,et al.  Effect of indapamide on the electromechanical properties of rat myometrium and rat portal vein. , 1986, The Journal of pharmacology and experimental therapeutics.

[37]  R Peto,et al.  Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.

[38]  R. N. Brogden,et al.  Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. , 1984, Drugs.

[39]  J. Savineau,et al.  Compared effects of indapamide, hydrochlorothiazide and chlorthalidone on electrical and mechanical activities in vascular smooth muscle. , 1981, European journal of pharmacology.

[40]  A. Carter,et al.  Hypotensive therapy in stroke survivors. , 1970, Lancet.

[41]  L. Kong,et al.  Chronic Diseases 4 Preventing chronic diseases in China , 2022 .